52
Participants
Start Date
September 30, 2011
Primary Completion Date
December 31, 2013
Study Completion Date
September 30, 2019
hu14.18-IL2 fusion protein
Given IV
isotretinoin
Given PO
sargramostim
Given SC
laboratory biomarker analysis
Correlative studies
Columbia University Medical Center, New York
New York Medical College, Valhalla
State University of New York Upstate Medical University, Syracuse
Roswell Park Cancer Institute, Buffalo
Penn State Hershey Children's Hospital, Hershey
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Children's Hospital of Philadelphia, Philadelphia
Children's National Medical Center, Washington D.C.
Sinai Hospital of Baltimore, Baltimore
Virginia Commonwealth University, Richmond
Childrens Hospital-King's Daughters, Norfolk
University of North Carolina, Chapel Hill
Duke University Medical Center, Durham
Carolinas Medical Center, Charlotte
Presbyterian Hospital, Charlotte
Children's Healthcare of Atlanta - Egleston, Atlanta
Florida Hospital, Orlando
Miami Children's Hospital, Miami
All Children's Hospital, St. Petersburg
Lee Memorial Health System, Fort Myers
University of Alabama at Birmingham, Birmingham
Vanderbilt-Ingram Cancer Center, Nashville
St. Jude Children's Research Hospital, Memphis
Kosair Children's Hospital, Louisville
University of Kentucky, Lexington
The Toledo Hospital/Toledo Children's Hospital, Toledo
Rainbow Babies and Childrens Hospital, Cleveland
Cleveland Clinic Foundation, Cleveland
Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati
The Children's Medical Center of Dayton, Dayton
Riley Hospital for Children, Indianapolis
Bronson Methodist Hospital, Kalamazoo
Kalamazoo Center for Medical Studies, Kalamazoo
Raymond Blank Children's Hospital, Des Moines
University of Wisconsin Hospital and Clinics, Madison
Saint Vincent Hospital, Green Bay
Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
Mayo Clinic, Rochester
University of Illinois, Chicago
Southern Illinois University, Springfield
Cardinal Glennon Children's Medical Center, St Louis
Washington University School of Medicine, St Louis
Tulane University Health Sciences Center, New Orleans
Children's Hospital-Main Campus, New Orleans
University of Arkansas for Medical Sciences, Little Rock
University of Oklahoma Health Sciences Center, Oklahoma City
Natalie W Bryant Cancer Center, Tulsa
Medical City Dallas Hospital, Dallas
Cook Children's Medical Center, Fort Worth
Children's Hospital Colorado, Aurora
Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
Primary Children's Medical Center, Salt Lake City
University of New Mexico Cancer Center, Albuquerque
Children's Hospital Los Angeles, Los Angeles
Rady Children's Hospital - San Diego, San Diego
Loma Linda University Medical Center, Loma Linda
University of California San Francisco Medical Center-Parnassus, San Francisco
University of Hawaii, Honolulu
Oregon Health and Science University, Portland
Seattle Children's Hospital, Seattle
Children's Oncology Group, Arcadia
Children's Hospital Central California, Madera
Childrens Hospital of Orange County, Orange
Connecticut Children's Medical Center, Hartford
Nemours Children's Clinic - Jacksonville, Jacksonville
University of Chicago Comprehensive Cancer Center, Chicago
Dana-Farber Cancer Institute, Boston
Morristown Memorial Hospital, Morristown
Overlook Hospital, Summit
Sanford USD Medical Center - Sioux Falls, Sioux Falls
Alberta Children's Hospital, Calgary
British Columbia Children's Hospital, Vancouver
Hospital for Sick Children, Toronto
The Montreal Children's Hospital of the MUHC, Montreal
Hospital Sainte-Justine, Montreal
National Cancer Institute (NCI)
NIH
Children's Oncology Group
NETWORK